Leerink Partners initiated coverage on Owens & Minor with a new price target
$OMI
Medical Specialities
Health Care
Leerink Partners initiated coverage of Owens & Minor with a rating of Market Perform and set a new price target of $24.00
Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
7/19/2024 | $24.00 → $19.00 | Neutral → Buy | Citigroup |
2/26/2024 | $24.00 | Market Perform | Leerink Partners |
1/3/2024 | $21.00 | Equal Weight | Barclays |
10/13/2022 | $52.00 → $18.00 | Buy → Neutral | Citigroup |
10/12/2022 | $43.00 → $17.00 | Buy → Underperform | BofA Securities |
10/12/2022 | $62.00 → $22.00 | Outperform → Neutral | Robert W. Baird |
4/26/2022 | $55.00 | Buy | Citigroup |
4/1/2022 | $43.00 | Neutral | Credit Suisse |
Citigroup upgraded Owens & Minor from Neutral to Buy and set a new price target of $19.00 from $24.00 previously
Leerink Partners initiated coverage of Owens & Minor with a rating of Market Perform and set a new price target of $24.00
Barclays initiated coverage of Owens & Minor with a rating of Equal Weight and set a new price target of $21.00